About Preclinical Disease and Prevention
The Preclinical Disease and Prevention unit is devoted to helping people identify and address their risk of developing or managing two of Australia’s most prevalent chronic diseases — cardiovascular disease and diabetes. The research of the Preclinical Disease and Prevention unit is predominantly undertaken in community settings with a focus on higher risk individuals.
The Preclinical Disease and Prevention unit conducts rigorous, multi-disciplinary clinical trial research to demonstrate the benefits of nurse-facilitated models of care. Embedded within these disease management programs are the use of mobile devices (such as “apps” or avatars) and telehealth (phone or video conferencing) to promote health behaviour change and implement gold standard care to enhance management. Integral to this work is nurse management to deliver personalised care that targets risk and protective factors to help higher risk individuals.
We collaborate with eminent cardiologists, endocrinologists, leading GP academics and Aboriginal health researchers. These partnerships, combined with the Unit’s expert team of research fellows, clinical researchers, nurses and technical and administrative support staff enable the Unit to carry out innovative research for improving the management of cardiovascular disease.
- Randomised controlled trials of disease management programs for primary and secondary prevention of cardiometabolic disease.
- Establishing the evidence for nurse-led models of care.
- Risk detection and surveillance using a combination of traditional and novel risk indicators.
- eHealth to achieve optimal patient care and outcomes.
- Mass data analyses of primary care management of cardiometabolic risk.